<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article article-type="research-article" dtd-version="3.0" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">ploscomp</journal-id>
<journal-title-group>
<journal-title>PLOS Computational Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1553-734X</issn>
<issn pub-type="epub">1553-7358</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pcbi.1004800</article-id>
<article-id pub-id-type="publisher-id">PCOMPBIOL-D-15-00671</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Enzymology</subject><subj-group><subject>Enzymes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Enzymes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Metabolic processes</subject><subj-group><subject>Glycolysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical compounds</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Carbohydrates</subject><subj-group><subject>Monosaccharides</subject><subj-group><subject>Glucose</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Organic chemistry</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Carbohydrates</subject><subj-group><subject>Monosaccharides</subject><subj-group><subject>Glucose</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Computer and information sciences</subject><subj-group><subject>Systems science</subject><subj-group><subject>System instability</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Systems science</subject><subj-group><subject>System instability</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Enzymology</subject><subj-group><subject>Enzyme chemistry</subject><subj-group><subject>Enzyme metabolism</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Metabolites</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Computer and information sciences</subject><subj-group><subject>Systems science</subject><subj-group><subject>System stability</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Systems science</subject><subj-group><subject>System stability</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical compounds</subject><subj-group><subject>Acids</subject><subj-group><subject>Ketones</subject><subj-group><subject>Pyruvate</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Stability of Ensemble Models Predicts Productivity of Enzymatic Systems</article-title>
<alt-title alt-title-type="running-head">Stability Predicts Production in Enzymatic Systems</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Theisen</surname>
<given-names>Matthew K.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lafontaine Rivera</surname>
<given-names>Jimmy G.</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Liao</surname>
<given-names>James C.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Bioengineering, University of California, Los Angeles, Los Angeles, California, United States of America</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, Los Angeles, California, United States of America</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>UCLA-DOE Institute, University of California, Los Angeles, Los Angeles, California, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Voit</surname>
<given-names>Eberhard O.</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Georgia Institute of Technology, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Analyzed the data: MKT JGLR JCL. Wrote the paper: MKT JGLR JCL. Conceived the idea: MKT JGLR JCL. Designed the computational experiments: MKT. Provided analysis codes: JGLR.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">liaoj@ucla.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<month>3</month>
<year>2016</year>
</pub-date>
<volume>12</volume>
<issue>3</issue>
<elocation-id>e1004800</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>4</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>2</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>Theisen et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pcbi.1004800"/>
<abstract>
<p>Stability in a metabolic system may not be obtained if incorrect amounts of enzymes are used. Without stability, some metabolites may accumulate or deplete leading to the irreversible loss of the desired operating point. Even if initial enzyme amounts achieve a stable steady state, changes in enzyme amount due to stochastic variations or environmental changes may move the system to the unstable region and lose the steady-state or quasi-steady-state flux. This situation is distinct from the phenomenon characterized by typical sensitivity analysis, which focuses on the smooth change before loss of stability. Here we show that metabolic networks differ significantly in their intrinsic ability to attain stability due to the network structure and kinetic forms, and that after achieving stability, some enzymes are prone to cause instability upon changes in enzyme amounts. We use Ensemble Modelling for Robustness Analysis (EMRA) to analyze stability in four cell-free enzymatic systems when enzyme amounts are changed. Loss of stability in continuous systems can lead to lower production even when the system is tested experimentally in batch experiments. The predictions of instability by EMRA are supported by the lower productivity in batch experimental tests. The EMRA method incorporates properties of network structure, including stoichiometry and kinetic form, but does not require specific parameter values of the enzymes.</p>
</abstract>
<abstract abstract-type="summary">
<title>Author Summary</title>
<p>A method of metabolic simulation called ensemble modelling for robustness analysis is used to predict the behavior intrinsic to the network structure (stoichiometry and kinetic form) of four enzymatic systems. Some network structures are shown to be prone to instability. Starting from a stable system, instability is also predicted to be caused by increasing amounts of certain enzymes. EMRA is a valuable tool for pathway design, particularly synthetic pathways which are uncontrolled and not stabilized through evolution.</p>
</abstract>
<funding-group>
<funding-statement>This work was supported by National Science Foundation (MCB- 1139318) (<ext-link ext-link-type="uri" xlink:href="http://www.nsf.gov" xlink:type="simple">www.nsf.gov</ext-link>), UCLA-DOE Institute for Genomics and Proteomics (<ext-link ext-link-type="uri" xlink:href="http://www.doe-mbi.ucla.edu/" xlink:type="simple">http://www.doe-mbi.ucla.edu/</ext-link>), and the U.S. Department of Energy Office of Science Biological and Environmental Research Program (<ext-link ext-link-type="uri" xlink:href="http://science.energy.gov/ber/" xlink:type="simple">http://science.energy.gov/ber/</ext-link>)), (DE-SC0012384, DE-SC0001060 and DE-SC0008744). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="7"/>
<table-count count="2"/>
<page-count count="18"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Metabolic systems typically operate either under a stable steady state or an oscillatory mode. A non-oscillatory unstable system may result in multiple problems, including depletion of metabolites essential for growth, accumulation of toxic intermediates, or depletion of cofactors in the pathway—all ultimately leading to loss of production or cell death. While systems with stable steady states or sustained oscillation have been studied extensively [<xref ref-type="bibr" rid="pcbi.1004800.ref001">1</xref>–<xref ref-type="bibr" rid="pcbi.1004800.ref006">6</xref>], to our knowledge metabolic systems prone to instability have not been investigated as much. Both stable (<xref ref-type="fig" rid="pcbi.1004800.g001">Fig 1A</xref>) or unstable (<xref ref-type="fig" rid="pcbi.1004800.g001">Fig 1B</xref>) system have a mathematical steady state (or fixed point), but the unstable steady state is not realizable in the physical world because any deviations from the steady state are amplified. Therefore, through evolution the unstable systems are selected against or stabilized by various levels of controls. However, the issue of stability is particularly important when engineering a novel pathway or altering an existing one.</p>
<fig id="pcbi.1004800.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1004800.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Schematic figure showing how instability can occur and how it can cause lower production in batch experiments.</title>
<p><bold>a-b)</bold> In a one-dimensional dynamical system, the sign of d<bold>ẋ</bold>/d<bold>x</bold> determines stability of a fixed point (<bold>ẋ</bold> = 0). If the sign of d<bold>ẋ</bold>/d<bold>x</bold> is negative <bold>(a)</bold>, the system is stable to stochastic perturbations from the fixed point. In contrast, if d<bold>ẋ</bold>/d<bold>x</bold> positive <bold>(b)</bold>, the fixed point is unstable. In a multivariate system, the analogous value is the maximum of the real parts of the eigenvalues of the Jacobian matrix. (i.e. if max(Re(Eig(Jac)))) is greater than 0 (the jacobian is singular), the fixed point will be unstable, if it is less than zero the fixed point will be stable unstable). <bold>c)</bold> Traditional global sensitivity analysis calculates the sensitivity coefficient which represents the derivative of steady state production with respect to enzyme amount. However, sensitivity analysis doesn’t investigate the likelihood of instability. Bifurcational robustness measures the distance between the reference steady state and the bifurcation point. <bold>d)</bold> A kinetic trap in which multiple reactions (v<sub>1</sub> &amp; v<sub>2</sub>) are competing for the same substrate (A). If the enzyme catalyzing v<sub>1</sub> increases greatly, it may cause instability by decreasing [A] so much that v<sub>2</sub> cannot continue.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1004800.g001" xlink:type="simple"/>
</fig>
<p>Furthermore, even starting from a stable steady state system, increasing an enzyme activity beyond a specific level may result in system failure (see <xref ref-type="fig" rid="pcbi.1004800.g001">Fig 1C</xref>) because the system enters an unstable region, resulting in loss of a productive steady state. The likelihood of losing stability is characterized by bifurcational robustness using Ensemble Modeling for Robustness analysis (EMRA) [<xref ref-type="bibr" rid="pcbi.1004800.ref007">7</xref>]. Instability caused by enzyme perturbation has been predicted in proposed synthetic pathways and natural pathways in previous analyses[<xref ref-type="bibr" rid="pcbi.1004800.ref007">7</xref>,<xref ref-type="bibr" rid="pcbi.1004800.ref008">8</xref>]. One means of stability loss, among other possibilities, is a kinetic trap (<xref ref-type="fig" rid="pcbi.1004800.g001">Fig 1D</xref>), resulting from a metabolic branch point within a cyclic pathway. Upon perturbation, a kinetic trap may cause a sudden, unexpected, and qualitative change in dynamic behavior (<xref ref-type="fig" rid="pcbi.1004800.g001">Fig 1C</xref>). Since cyclic pathways are common in metabolism, particularly when cofactor recycling are involved, such examples are copious. The bifurcational robustness is a measure of how far an enzyme amount must be perturbed before bifurcation occurs (<xref ref-type="fig" rid="pcbi.1004800.g001">Fig 1C</xref>). Sudden system failure due to entering an unstable regime differs from the gradual deterioration of performance characterized by local sensitivity analysis. Sensitivity analysis, Biochemical Systems Theory [<xref ref-type="bibr" rid="pcbi.1004800.ref009">9</xref>–<xref ref-type="bibr" rid="pcbi.1004800.ref013">13</xref>], or metabolic control analysis (MCA) [<xref ref-type="bibr" rid="pcbi.1004800.ref014">14</xref>] is concerned with identifying the sensitivity coefficient (<xref ref-type="fig" rid="pcbi.1004800.g001">Fig 1C</xref>), which is the derivative of steady state production flux with respect to enzyme amount. In this work, we further examine the tendency for a metabolic system to be unstable based on their intrinsic network structure, which is determined by the network stoichiometry and kinetic rate laws. One way that this work builds on global sensitivity analysis is in that it focuses heavily on what we term the bifurcational robustness (<xref ref-type="fig" rid="pcbi.1004800.g001">Fig 1C</xref>), rather than the value of the sensitivity coefficient.</p>
<p>In previous uses of EMRA, unstable parameter sets found while constructing ensembles were discarded [<xref ref-type="bibr" rid="pcbi.1004800.ref007">7</xref>,<xref ref-type="bibr" rid="pcbi.1004800.ref008">8</xref>]. Here, we examine the intrinsic probability for a system to be unstable. This is fundamentally distinct from the tendency to bifurcate upon change from a stable steady state. In addition, previous EMRA simulations were applied to continuous processes. However, production experiments using enzymatic systems—whether <italic>in vitro</italic> or <italic>in vivo</italic>—are often carried out as a batch system due to practical considerations. Thus, it is unclear how simulations from a continuous mode can inform experimental strategies for new metabolic pathways which are investigated in batch or cell free experiments. Using four metabolic systems, we showed that the instability problem discussed above is indeed an issue, even with batch experiments. Interestingly, this type of abrupt change is observed in common biological systems, including glycolysis. The results suggest that the stability issues may be more prevalent than previously appreciated.</p>
<sec id="sec002">
<title>Systems description</title>
<p>We use the following enzymatic systems as examples for our investigation. Three of these systems have been described previously and some experimental data are available to validate our predictions. The other system (glucose to isoprene pathway) has not been experimentally investigated.</p>
</sec>
<sec id="sec003">
<title>Methanol Condensation Cycle (MCC)</title>
<p>Methanol condensation cycle (MCC) (<xref ref-type="fig" rid="pcbi.1004800.g002">Fig 2A</xref>) is a metabolic pathway to convert methanol to higher alcohols with 100% theoretical carbon yield, in contrast to natural pathways like ribulose monophosphate (RuMP) which have a maximum of 67% theoretical carbon yield due to the decarboxylation of pyruvate [<xref ref-type="bibr" rid="pcbi.1004800.ref015">15</xref>]. The core of the pathway creates a C-C bond between two formaldehyde molecules derived from methanol for the generation of acetyl-phosphate, which can be enzymatically converted to acetate or ethanol.</p>
<fig id="pcbi.1004800.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1004800.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Schematics showing four enzymatic systems which can be investigated by EMRA.</title>
<p><bold>a)</bold> A methanol condensation cycle (MCC) which converts formaldehyde to acetyl-phosphate with 100% carbon efficiency. Acetate can be generated enzymatically. <bold>b)</bold> A molecular purge valve which dissipates reducing power in order to convert pyruvate to polyhydroxybutyrate (PHB) in a redox balanced way. <bold>c)</bold> A chimeric glycolysis system which converts glucose to lactate in a redox- and ATP-balanced route. It uses a non-phosphorylating GapN to maintain ATP balance. The corresponding route through standard Embden-Meyerhof-Parnas (EMP) glycolysis is shown with blue enzyme labels. <bold>d)</bold> Glucose to isoprene pathway which uses NADPH-dependent glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and pyruvate dehydrogenase (PDH). An NADPH drain is required to maintain redox balance. This pathway is also ATP-balanced. G6P inhibition is also considered in this system.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1004800.g002" xlink:type="simple"/>
</fig>
<p>In this cycle, formaldehyde is incorporated into ribulose-5-phosphate (Ru5P) (<xref ref-type="fig" rid="pcbi.1004800.g002">Fig 2A</xref>) to generate hexulose-6-phosphate (H6P) by hexulose phosphate synthase (Hps). H6P is then isomerized to fructose-6-phosphate (F6P) which can be cleaved by phosphoketolase. Erythrulose-4-phosphate (E4P) and F6P can then recombine via transaldolase, transketolase and isomerases (Tal, Tkt, Rpe, Rpi) to regenerate Ru5P. Alternately, xylulose-5-phosphate (X5P) can be cleaved by phosphoketolase, yielding G3P and acetyl-phosphate. G3P is then shuffled with F6P by transketolase to generate E4P and X5P, which can proceed to regenerate Ru5P via Tal, Tkt, Rpe, and Rpi. The X5P- and F6P-cleaving activities of phosphoketolase are referred to as Xpk and Fpk, respectively, and the pathway is investigated with different combinations of these activities.</p>
</sec>
<sec id="sec004">
<title>Pyruvate to poly-hydroxybutyrate</title>
<p>A molecular purge valve for the production of polyhydroxybutyrate from pyruvate <italic>in vitro</italic> was demonstrated by Opgenorth <italic>et al</italic> (<xref ref-type="fig" rid="pcbi.1004800.g002">Fig 2B</xref>) [<xref ref-type="bibr" rid="pcbi.1004800.ref016">16</xref>]. This system needs special attention to achieve redox balance, since pyruvate has a more reduced oxidation state than the product. To alleviate this cofactor imbalance, a method for dissipating excess reducing equivalents, termed a molecular purge valve, was designed for the conversion of pyruvate to downstream products like isoprene and poly(hydroxybutyrate) (PHB). Two different pyruvate dehydrogenases (PDH) were used in the system—one with cofactor specificity for NADPH and one with specificity for NADH. The downstream pathway enzymes use NADPH to reduce metabolites and an NADH oxidase (NoxE) to dissipate the generated NADH. From two acetyl-CoA molecules, two enzymes are required to generate the final product PHB.</p>
</sec>
<sec id="sec005">
<title>A chimeric ATP-balanced glycolysis system</title>
<p>A chimeric glycolysis system was demonstrated by Ye <italic>et al</italic> [<xref ref-type="bibr" rid="pcbi.1004800.ref017">17</xref>] (<xref ref-type="fig" rid="pcbi.1004800.g002">Fig 2C</xref>). Canonical Embden-Meyerhof-Parnas (EMP) glycolysis generates a net of two ATP per glucose. In the chimeric system, a non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase (GAPN) was used. This results in a system which is ATP balanced, making it more convenient for <italic>in vitro</italic> assays. Additionally, the system is NADH balanced since the final product was lactate, which has the same redox state as glucose.</p>
</sec>
<sec id="sec006">
<title>Glucose to isoprene system</title>
<p>A system is considered for the conversion of glucose to isoprene (<xref ref-type="fig" rid="pcbi.1004800.g002">Fig 2D</xref>). NADPH-dependent glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and NADPH-dependent pyruvate dehydrogenase are used in the pathway. NADPH is used since the downstream reactions in isoprene synthesis use NADPH. The pathway converts three glucose to two isoprene molecules. Interestingly, this pathway is also ATP-balanced, with the ATP generated by the glycolytic pathway being used stoichiometrically downstream in the isoprene pathway reactions. However, to maintain redox balance, NADPH must be drained from the system, potentially via an oxidase or similar enzyme. This system is investigated both with and without a substrate-level regulation of glucokinase (GK) by G6P, implemented using an irreversible version of modular rate laws [<xref ref-type="bibr" rid="pcbi.1004800.ref018">18</xref>] proposed by Liebermeister. The kinetic form used is known as competitive inhibition, though many other kinetic forms are plausible. Inhibition of this step by G6P is well-known. For example, a human enzyme catalyzing this reaction is G6P-inhibited [<xref ref-type="bibr" rid="pcbi.1004800.ref019">19</xref>]. These equations show the effective kinetic forms of glucokinase used without and with regulation:
<disp-formula id="pcbi.1004800.e001">
<alternatives>
<graphic id="pcbi.1004800.e001g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1004800.e001" xlink:type="simple"/>
<mml:math display="block" id="M1">
<mml:mrow><mml:mi>N</mml:mi><mml:mi>o</mml:mi><mml:mspace width="0.25em"/><mml:mi>R</mml:mi><mml:mi>e</mml:mi><mml:mi>g</mml:mi><mml:mi>u</mml:mi><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mo>:</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>G</mml:mi><mml:mi>K</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mi>l</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi>G</mml:mi><mml:mi>l</mml:mi><mml:mi>c</mml:mi></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mi>A</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mi>A</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mi>l</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi>G</mml:mi><mml:mi>l</mml:mi><mml:mi>c</mml:mi></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac></mml:mrow>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pcbi.1004800.e002">
<alternatives>
<graphic id="pcbi.1004800.e002g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1004800.e002" xlink:type="simple"/>
<mml:math display="block" id="M2">
<mml:mrow><mml:mi>W</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mspace width="0.25em"/><mml:mi>G</mml:mi><mml:mn>6</mml:mn><mml:mi>P</mml:mi><mml:mspace width="0.25em"/><mml:mi>I</mml:mi><mml:mi>n</mml:mi><mml:mi>h</mml:mi><mml:mi>i</mml:mi><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mspace width="0.25em"/><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>G</mml:mi><mml:mi>K</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mtext>max</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mi>l</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi>G</mml:mi><mml:mi>l</mml:mi><mml:mi>c</mml:mi></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mi>A</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mi>A</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mi>G</mml:mi><mml:mi>l</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi>A</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi>G</mml:mi><mml:mi>l</mml:mi><mml:mi>c</mml:mi></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi>G</mml:mi><mml:mn>6</mml:mn><mml:mi>P</mml:mi></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>e</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi><mml:mo>,</mml:mo><mml:mi>A</mml:mi><mml:mi>T</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac></mml:mrow>
</mml:math>
</alternatives>
</disp-formula></p>
</sec>
</sec>
<sec id="sec007" sec-type="results">
<title>Results</title>
<sec id="sec008">
<title>Network intrinsic stability differs among systems and is different from bifurcational robustness upon perturbation</title>
<p>We used the four systems described in <xref ref-type="fig" rid="pcbi.1004800.g002">Fig 2</xref> to examine the stability problem. In particular, we investigated how network structure affects the intrinsic possibility of reaching stability. Previous EMRA work starts from an ensemble of parameter sets that give the same reference steady state, and discards the parameter sets that generate a Jacobian matrix with a real part of an Eigenvalue greater than zero, which indicates instability.</p>
<p>However, experimental systems are not guaranteed to be stable or reach a steady state. To place stability and steady state in a context which is more meaningful to experimental efforts, enzyme parameters were chosen completely at random, and the systems were then integrated in time domain to determine if a productive steady state was reached (<xref ref-type="fig" rid="pcbi.1004800.g003">Fig 3A</xref>, dark blue bars). This method is more representative of experimental efforts which often have either little or indirect control over enzyme amount or activity (<italic>in vivo</italic>), or don’t have rational methods for pathway balancing (both <italic>in vivo</italic> and <italic>in vitro</italic>). Interestingly, the results show that pathways have very different likelihoods of resulting in a steady state (<xref ref-type="fig" rid="pcbi.1004800.g003">Fig 3A</xref>, dark blue). The glucose to isoprene system had only 21% of randomly generated parameter sets reaching a non-trivial (non-zero) steady state. This could be because it is a relatively large system in terms of enzyme number and uses two different cofactors (NADPH and ATP). A large system may be less likely to reach a steady state. If each enzyme has an acceptable range of values, then in a large system it is more likely that at least one of these values would be outside the range, resulting in system instability. However, when regulation of glucokinase was introduced via activation by ATP and inhibition by ADP, the likelihood of productivity jumped to 36% (<xref ref-type="fig" rid="pcbi.1004800.g003">Fig 3A</xref>). Overall, these results show that intrinsic pathway structure and kinetic forms (including regulation) have a strong influence on possibility of reaching a productive steady state. The result is a varying, and sometimes low, likelihood of achieving stability and productivity. Thus, finding rational ways to balance pathways is an important goal which can improve and accelerate the pathway development process.</p>
<fig id="pcbi.1004800.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1004800.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Characterizing intrinsic stability of different pathway systems.</title>
<p><bold>a)</bold> For different pathways, two measures of intrinsic stability are presented. First, in dark blue, is the fraction of unconstrained, random parameter sets which reach a productive steady state. Second, in light blue, is the fraction of EMRA-determined parameter sets constrained to a steady state which are also stable. The intrinsic stability of pathways differs greatly between pathways, and also depending on which measure is used. Thus, a rational method of pathway balancing would be useful. (SD &lt; 2% for all systems, n = 3 x 1000 parameter sets). Since phoshoketolase has two activities, cleaving either F6P (called Fpk) or X5P (called Xpk), we investigated used a ratio of Fpk/Xpk activites, 1:3. <bold>b)</bold> A representation of how steady state is not always stable. After perturbation from a constrained steady state, the fraction of parameter sets which retain stability tends to decrease, and steady state flux may change. Eventually, a parameter set may become unstable after perturbation.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1004800.g003" xlink:type="simple"/>
</fig>
<p>If the enzyme parameters were first constrained to a fixed point by solving for parameter values which give reaction rates equal to the reference flux, then the probability of attaining stability is greatly increased. While this is not practical in experiments, the method proves useful in model construction. We found that (<xref ref-type="fig" rid="pcbi.1004800.g003">Fig 3A</xref>, light blue bars) the fraction of fixed points which were stable varied depending on the network structure. While most systems showed at least 99% of the parameter sets sampled to be at a stable steady state, the MCC (Xpk-only) system showed only 61% of parameter sets to be stable. Although for some systems the fraction of stable steady states is similar—5 systems which all show at least 99% stability by this measure—they have varying tendency to lose stability upon perturbation (<xref ref-type="fig" rid="pcbi.1004800.g003">Fig 3B</xref>). Starting from the reference state, where parameter sets are chosen under the fixed point constraint, the region of instability could grow when enzyme parameter changes (<xref ref-type="fig" rid="pcbi.1004800.g003">Fig 3B</xref>). Depending on the structure of the system, the instability region might grow in a different fashion upon perturbation, and eventually some might lose stability. This shows that stability of fixed points in metabolic systems is not guaranteed and that stability could be a critical factor in metabolic systems.</p>
</sec>
<sec id="sec009">
<title>Stability of continuous systems upon perturbation can inform results of batch systems</title>
<p>EMRA uses continuous production models to simulate enzymatic systems. However, many experiments, including <italic>in vivo</italic> and <italic>in vitro</italic>, are conducted as batch processes. Thus, it’s not clear how a perturbation which causes bifurcation in a continuous system will inform the batch experiment. Where a pseudo-steady state may exist, the pseudo-steady state behavior can be predicted by the continuous model. In these systems, if a parameter set resides in a domain where no stable steady state exists in the continuous mode, then no stable pseudo-steady state exists in the batch mode. This can be justified by locally linearizing the input function to convert a pseudo-steady batch system to a continuous system. However, an experimentalist measuring only the product output at the end point would not detect the lack of stability. In this case, the product yield will gradually decrease even when the system has entered an instability region.</p>
<p>To show how the existence of a continuous bifurcation could manifest itself in a batch system, we simulated a batch system in time domain. First, stable parameter sets were generated via EMRA in a continuous MCC system using Fpk/Xpk ratio as 1:3. Then, the parameter sets were integrated using the continuation method to increase the phosphoketolase level until instability occurs, increasing V<sub>max</sub> for Fpk &amp; Xpk at the same ratio. A representative parameter set is plotted in <xref ref-type="fig" rid="pcbi.1004800.g004">Fig 4A</xref> to show the effect of increased phosphoketolase on continuous steady state acetate flux up to the point of instability. As phosphoketolase increases, the flux towards product increases slightly before decreasing and finally becoming unstable.</p>
<fig id="pcbi.1004800.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1004800.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Investigating the instability in the MCC pathway using Fpk/Xpk ratio as 1:3.</title>
<p><bold>a)</bold> In a continuous system, an arbitrary parameter set determined by EMRA is perturbed up and down with respect to phosphoketolase, on the X-axis. On the Y-axis, the continuous, steady state, acetate flux is plotted. As phosphoketolase increases, the system bifurcates at ~1.5x increase. <bold>b)</bold> Time domain simulation is performed, at different amounts phosphoketolase (PK). The final titer for each condition is plotted. The production gradient appears gradual, but is the result of a sudden instability. <bold>c)</bold> The production rate for acetate is shown for each phosphoketolase amount over time. In the stable conditions (1x &amp; 1.1x), production rate reaches a constant, implying the system enters a “pseudo-steady state”, until substrate depletes. In the other conditions, production rate is never steady, but decreases over time. <bold>d)</bold> The amount of acetate is plotted over time. It is observed that as the amount of phosphoketolase increases beyond bifurcation, the production decreases. <bold>e)</bold> At the 1x and 2x conditions, the concentrations of G3P and F6P are plotted. In the 1x condition, F6P is maintained at a nonzero-level throughout production, while in the 2x condition, it is quickly depleted and G3P accumulates. <bold>f)</bold> The R5P &amp; X5P levels are plotted with time in the 1x and 2x conditions. <bold>g)</bold> Data from Bogorad <italic>et al</italic> [<xref ref-type="bibr" rid="pcbi.1004800.ref015">15</xref>] shows that as phosphoketolase level increased, the amount of acetate produced by the cycle decreased, supporting a link between instability in a continuous system and production in an analogous batch system. An icon shows this data is experimental.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1004800.g004" xlink:type="simple"/>
</fig>
<p>This parameter set was found to become unstable at a ~1.5-fold increase of phosphoketolase. Different amounts of phosphoketolase perturbation (1x, 1.1x, 1.7x, 1.8x, 2x, 10x –multiplier applied to both Fpk &amp; Xpk V<sub>max</sub> values) were chosen to show the dynamic response of the system in a batch simulation. All rate equations, parameter values and initial conditions were kept the same as in the continuous model (i.e. all starting metabolite concentrations were normalized to unity), except that starting formaldehyde concentration was multiplied by 200 and the “in” and “out” reactions used in the continuous mode were eliminated to observe product accumulation in time domain simulation of the batch system. 200-fold increase in initial formaldehyde concentration was chosen arbitrarily to signify a batch reaction, in which the starting substrate was included as a single charge instead of being fed over time. It was found to adequately demonstrate the phenomena we were interested in, though other values could have worked as well. See Tables <xref ref-type="table" rid="pcbi.1004800.t001">1</xref> and <xref ref-type="table" rid="pcbi.1004800.t002">2</xref>.</p>
<table-wrap id="pcbi.1004800.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1004800.t001</object-id>
<label>Table 1</label> <caption><title>Summary of difference between flux equation parameter values in continuous and batch simulations of the MCC system (<xref ref-type="fig" rid="pcbi.1004800.g004">Fig 4</xref>).</title></caption>
<alternatives>
<graphic id="pcbi.1004800.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1004800.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center"/>
<th align="center">Formaldehyde Input Exchange Rxn, V<sub>max</sub></th>
<th align="center">Acetate Output Exchange Rxn, V<sub>max</sub></th>
<th align="center">All Other V<sub>max</sub></th>
<th align="center"><inline-formula id="pcbi.1004800.e003"><alternatives><graphic id="pcbi.1004800.e003g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1004800.e003" xlink:type="simple"/><mml:math display="inline" id="M3"><mml:mover accent="true"><mml:mi>λ</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math></alternatives></inline-formula> (K<sub>m,</sub> K<sub>eq</sub>, etc.)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center">Continuous</td>
<td align="center">Constrained to Reference Input Flux</td>
<td align="center">Constrained to Reference Output Flux</td>
<td align="center">Constrained to Reference Flux</td>
<td align="center">Selected from random distribution</td>
</tr>
<tr>
<td align="center">Batch</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">Same values as above</td>
<td align="center">Same values as above</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<table-wrap id="pcbi.1004800.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1004800.t002</object-id>
<label>Table 2</label> <caption><title>Comparison of normalized metabolite concentration values in continuous and batch simulations performed on the MCC system (<xref ref-type="fig" rid="pcbi.1004800.g004">Fig 4</xref>).</title></caption>
<alternatives>
<graphic id="pcbi.1004800.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1004800.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center"/>
<th align="center">CH<sub>2</sub>O</th>
<th align="center">Ru5P</th>
<th align="center">H6P</th>
<th align="center">F6P</th>
<th align="center">E4P</th>
<th align="center">S7P</th>
<th align="center">G3P</th>
<th align="center">X5P</th>
<th align="center">R5P</th>
<th align="center">AcP</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center">Normalized <italic>Continuous Steady State</italic> Metabolite Concentration, <inline-formula id="pcbi.1004800.e004"><alternatives><graphic id="pcbi.1004800.e004g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1004800.e004" xlink:type="simple"/><mml:math display="inline" id="M4"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mtext>X</mml:mtext><mml:mo>¯</mml:mo></mml:mover><mml:mtext>i</mml:mtext></mml:msub></mml:mrow></mml:math></alternatives></inline-formula></td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
</tr>
<tr>
<td align="center">Normalized <italic>Batch Initial</italic> Metabolite Concentration, <inline-formula id="pcbi.1004800.e005"><alternatives><graphic id="pcbi.1004800.e005g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1004800.e005" xlink:type="simple"/><mml:math display="inline" id="M5"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mtext>X</mml:mtext><mml:mo>¯</mml:mo></mml:mover><mml:mtext>i</mml:mtext></mml:msub></mml:mrow></mml:math></alternatives></inline-formula></td>
<td align="center">200</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
<td align="center">1</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<p>Interestingly, the final batch production observed for this system decreases gradually as phosphoketolase (PK) amount (<xref ref-type="fig" rid="pcbi.1004800.g004">Fig 4B</xref>) increases. In the continuous system, the underlying phenomenon is instability, a step change in the nature of the steady state. In the corresponding batch system, pseudo-steady state disappears because of instability. However, the product formation does not stop until key intermediates are depleted. Batch acetate production rate over time is plotted in <xref ref-type="fig" rid="pcbi.1004800.g004">Fig 4C</xref>. For the stable 1x and 1.1x conditions, a pseudo-steady state was achieved in which acetate production rate reached a constant level, only decreasing when the formaldehyde had been consumed. However, for the conditions which are past the instability point (1.7x – 10x), a steady rate of acetate production is never achieved. Instead, the rate decreases monotonically until it reaches zero. The productivity of the 10x condition falls the fastest, eventually resulting in the lowest production. This shows that a decrease in production, even gradually, in a batch system could be associated with an instability issue in an analogous continuous system. In <xref ref-type="fig" rid="pcbi.1004800.g004">Fig 4D</xref>, the acetate concentration over time is plotted to show how the system evolves over time.</p>
<p>For systems that are stable, because the initial concentration of the starting substrate is much higher than the K<sub>m</sub> value of the uptake system, the rate of input holds largely constant until the substrate concentration approaches the Km value. During this time, the system is operating under a pseudo-steady state similar to a stable continuous system. This is seen in <xref ref-type="fig" rid="pcbi.1004800.g004">Fig 4</xref> for 1x and 1.1x phosphoketolase concentrations. Thus, the property of continuous system simulation carries over, until substrate concentration approaches K<sub>m</sub>. Thus, the system is run almost the same as in a continuous system in the first 50 min time units or so (<xref ref-type="fig" rid="pcbi.1004800.g004">Fig 4C</xref>), when most of the acetate is produced (<xref ref-type="fig" rid="pcbi.1004800.g004">Fig 4D</xref>)</p>
<p>For systems that are unstable (<xref ref-type="fig" rid="pcbi.1004800.g004">Fig 4</xref>, 1.7x, 1.8x, 2x, 10x phosphoketolase concentrations), the output flux was not able to reach a steady-state (<xref ref-type="fig" rid="pcbi.1004800.g004">Fig 4C</xref>), and it decreases rapidly from the start and approaches zero despite the presence of the initial substrate. The cumulative product formed (acetate) is the integral of flux over time (<xref ref-type="fig" rid="pcbi.1004800.g004">Fig 4D</xref>), which decreases as the system moves further away from the bifurcation point.</p>
<p>Additionally, we investigated the mechanism by which the bifurcation causes decreased production. In the 1x condition, F6P is maintained at a nonzero-level throughout production, while in the 2x condition, it is quickly depleted (<xref ref-type="fig" rid="pcbi.1004800.g004">Fig 4E</xref>). R5P and X5P are also shown to deplete quickly in the 2x condition (<xref ref-type="fig" rid="pcbi.1004800.g004">Fig 4F</xref>). Thus, it is the depletion of these cycle intermediates which causes cycle failure. A previous experimental effort ([<xref ref-type="bibr" rid="pcbi.1004800.ref020">20</xref>], data reproduced in <xref ref-type="fig" rid="pcbi.1004800.g004">Fig 4G</xref>) showed that in <italic>in vitro</italic> enzymatic experiments, the batch production of acetate with from formaldehyde reached a local maximum with respect to phosphoketolase amount, supporting the EMRA analysis. In sum, EMRA could potentially have useful insights into experimental systems, by identifying enzymes which may be most sensitive to bifurcation, and how they affect the system in question.</p>
</sec>
<sec id="sec010">
<title>EMRA predicts behavior of a molecular purge valve</title>
<p>A purge valve system converting pyruvate to PHB was analyzed. Each enzyme is represented by a canonical Michaelis-Menten kinetic rate law, and the reference flux is fixed since there are no degrees of freedom. EMRA methodology was implemented in this system to show the effects of perturbation of each enzyme. High NADPH-dependent PDH (PDH<sup>NADPH</sup>) (<xref ref-type="fig" rid="pcbi.1004800.g005">Fig 5B</xref>) and low NADH-dependent PDH (PDH<sup>NADH</sup>) resulted in the most stability for the pathway. PDH<sup>NADH</sup> must be low to prevent too much pyruvate from taking this route which generates unusable NADH reducing power, while PDH<sup>NADPH</sup> must be high to ensure that enough NADPH is generated to allow for 100% yield from acetyl-CoA to PHB. The imbalance of these activities may cause system instability, according to EMRA. Indeed, the PHB pathway was experimentally demonstrated to have reduced production with a lower ratio of PDH<sup>NADPH</sup>:PDH<sup>NADH</sup> [<xref ref-type="bibr" rid="pcbi.1004800.ref016">16</xref>] (<xref ref-type="fig" rid="pcbi.1004800.g005">Fig 5C</xref>), matching the results of EMRA.</p>
<fig id="pcbi.1004800.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1004800.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Stability of a biosynthetic purge valve for production of isoprenoids by dissipation of reducing equivalents.</title>
<p><bold>a)</bold> Pathway schematic showing cofactor requirements. <bold>b)</bold> Stability profiles predicted by EMRA (n = 1000) as enzyme amounts vary. It is shown that to maintain stability, high levels of PDH<sup>NADP</sup> and low levels of PDH<sup>NAD</sup> are required. <bold>c)</bold> Data from ([<xref ref-type="bibr" rid="pcbi.1004800.ref017">17</xref>], <xref ref-type="fig" rid="pcbi.1004800.g004">Fig 4</xref>) which shows that a high ratio of PDH<sup>NADP</sup>: PDH<sup>NAD</sup> is required for optimal performance of the pathway. Image analysis of line graph figure from reference yielded numerical data to generate the bar graph shown. (1) indicates NADH-dependent PDH and (2) indicates NADPH-dependent PDH. An icon shows this data is experimental.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1004800.g005" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec011">
<title>EMRA predicts chimeric glycolysis system’s sensitivity to glucose feed rate</title>
<p>Another example of EMRA application is in a thermotolerant, cell-free glycolysis system which was demonstrated for the production of lactate from glucose by Ye <italic>et al</italic> (<xref ref-type="fig" rid="pcbi.1004800.g006">Fig 6A</xref>) [<xref ref-type="bibr" rid="pcbi.1004800.ref017">17</xref>]. Canonical Embden-Meyerhof-Parnas (EMP) glycolysis generates two net ATP per glucose, (<xref ref-type="fig" rid="pcbi.1004800.g006">Fig 6A</xref>, Gap &amp; Pgk enzymes). However, in the chimeric system, to prevent cofactor imbalance, a non-phosphorylating glyceraldehade-3-phosphate dehydrogenase (GapN)[<xref ref-type="bibr" rid="pcbi.1004800.ref021">21</xref>] was used—resulting in a net balance of ATP and NADH from glucose to lactate. Again, the system was modeled using EMRA methodology. The results show that increased glucokinase (GK) amount and glucose feed rate (<xref ref-type="fig" rid="pcbi.1004800.g006">Fig 6B</xref>, GK, IN) may cause instability.</p>
<fig id="pcbi.1004800.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1004800.g006</object-id>
<label>Fig 6</label>
<caption>
<title>The ATP-balanced synthetic chimeric glycolysis pathway from glucose to lactate [<xref ref-type="bibr" rid="pcbi.1004800.ref017">17</xref>].</title>
<p>a) Pathway schematic contrasting cofactor production between standard Canonical Embden-Meyerhof-Parnas (EMP) glycolysis (Gap &amp; Pgk, red lettering) with the chimeric non-phosphorylating GapN system. b) EMRA stability profiles (n = 1000) as enzyme amounts and glucose feed rate (IN) vary. Glucose feed rate is shown to produce moderate instability at higher levels. c) Data from (Fig 6A, [<xref ref-type="bibr" rid="pcbi.1004800.ref017">17</xref>]) which shows that increased glucose feed rate can cause lower production. An icon shows this data is experimental. d-e) Simulation of fed-batch production of a sample parameter set for the chimeric glycolysis system. Numerical integration of time domain behavior shows instability at higher feed rates caused by ATP depletion and resulting in lower overall lactate production. Priming intermediates are fed in the same proportion as the experimental condition, and feed rates are also demonstrated in the same proportion (1, 2, 4). d) ATP concentration over time at the three different glucose feed rates. e) Lactate production over time at three different glucose feed rates.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1004800.g006" xlink:type="simple"/>
</fig>
<p>This system was experimentally tested for lactate production at different glucose feed rates (<xref ref-type="fig" rid="pcbi.1004800.g006">Fig 6C</xref>, data from Ye <italic>et al</italic> [<xref ref-type="bibr" rid="pcbi.1004800.ref017">17</xref>]). It was found that beyond a certain point, increasing glucose feed rate reduced lactate production, even if the same total amount of glucose had been fed, matching the instability to feed rate (IN) predicted by EMRA. The instability apparently occurs by the depletion of ATP by glucokinase. ATP is required for both glucokinase and phosphofructokinase (PFK). However, if glucose is fed too quickly, ATP may become depleted by glucokinase before it can be regenerated in lower glycolysis. A time domain simulation of this system was carried out using initial conditions similar to the experimental conditions reported [<xref ref-type="bibr" rid="pcbi.1004800.ref017">17</xref>] (<xref ref-type="fig" rid="pcbi.1004800.g006">Fig 6D and 6E</xref>) and a parameter set from EMRA which became unstable after increase of feed rate. The time domain simulation showed that at reference feed rate (1x), ATP level is maintained and lactate production continues. However, at 4x feed rate, the ATP is depleted and the lactate production stops.</p>
<p>EMRA was also carried out on canonical EMP glycolysis converting glucose to lactate and similar instabilities were found (<xref ref-type="supplementary-material" rid="pcbi.1004800.s001">S1 Fig</xref>). In both systems, reduction in PFK activity was shown to strongly increase chance of instability. This is because once a metabolite is past PFK, it may be used to regenerate ATP, so it’s important to ensure that the flux past PFK is sufficient to supply ATP for all of upper glycolysis. However, it’s more paradoxical that an increase in an enzyme would cause productivity and instability issues, particularly glucokinase, or even feed rate.</p>
</sec>
<sec id="sec012">
<title>EMRA predicts unstable enzymes in uncharacterized system from glucose to isoprene</title>
<p>To demonstrate the utility of EMRA in identifying potential points of instability, a not yet characterized pathway producing isoprene from glucose was investigated with EMRA (full pathway stoichiometry in <xref ref-type="supplementary-material" rid="pcbi.1004800.s008">S7 Table</xref>). The pathway is ATP-balanced and maintains redox balance using an NADPH drain. EMRA identifies that the NADPH drain must be balanced, not too low or too high. GK &amp; IN must not be too high, while all other enzymes must only not be too low (<xref ref-type="fig" rid="pcbi.1004800.g007">Fig 7B</xref>). By introducing regulation of GK using modular rate laws [<xref ref-type="bibr" rid="pcbi.1004800.ref018">18</xref>], the fraction of productive steady states increased (<xref ref-type="fig" rid="pcbi.1004800.g003">Fig 3A</xref>). The stability to perturbation is also slightly improved for feed rate (IN), GK and PFK (<xref ref-type="fig" rid="pcbi.1004800.g007">Fig 7B</xref>).</p>
<fig id="pcbi.1004800.g007" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1004800.g007</object-id>
<label>Fig 7</label>
<caption>
<title>An NADPH-dependent pathway from glucose to isoprene.</title>
<p><bold>a)</bold> A pathway schematic showing an outline of the enzymatic reactions, cofactor flow, and regulation added (glucokinase). <bold>b)</bold> EMRA profiles for all (n = 1000) enzymes in the unregulated isoprene pathway in blue. EMRA profiles for all (n = 1000) enzymes in the GK-regulated isoprene pathway in red. Select enzymes are highlighted to show their position in the pathway. The enzymes dealing with ATP cycling are most changed by the presence of regulation.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1004800.g007" xlink:type="simple"/>
</fig>
<p>Interestingly, the NADPH drain is unstable to both decrease and increase. This could be because if the rate is too low, then NADP<sup>+</sup> is not sufficiently available for GAPDH, and lower glycolysis is unable to regenerate ATP needed for earlier in glycolysis and later in the pathway–while if the rate is too high, NADPH will not be available for the biosynthetic steps of the isoprene pathway. This analysis shows that a longer pathway has many complex, interacting factors that can cause instability and that EMRA is able to identify some of these potential issues. Similar to the previously simulated glycolysis system, glucokinase, (GK) and phosphofructokinase (PFK) and feed rate (IN) showed some instability. Other enzymes show less sensitivity upon increase (<xref ref-type="fig" rid="pcbi.1004800.g007">Fig 7B</xref>). Instability caused by decreasing enzyme concentration is common and seen in most if not all pathways.</p>
<p>A rational experimental plan for this pathway would thus focus on having sufficiently high levels of most enzymes (all except feed, glucokinase and drain), for example, by ensuring the total activity of each enzyme is significantly higher than the feed rate. Ensuring these enzymes are at a high level would ensure both stability, according to EMRA results, and the possibility of maximum productivity. For enzymes which become unstable at higher levels, more optimization is required. Levels of glucokinase, NADPH drain, and feed rate should be varied in order to avoid instability and to find the highest productivity condition. This significantly narrows the focus from 21 variables to just 3.</p>
</sec>
</sec>
<sec id="sec013" sec-type="conclusions">
<title>Discussion</title>
<p>The results show that EMRA has potential to be a valuable tool for investigating the propensity for stability of complex enzymatic pathways without <italic>a priori</italic> knowledge of specific enzyme parameter values. In three cases presented, (MCC, molecular purge valve, chimeric glycolysis) the experimental investigators were able to heuristically identify productivity issues <italic>ad hoc</italic>, but EMRA is able to unify all these results with a theoretical framework based on instability. Importantly, although some of the phenomena were experimentally determined, it was not necessarily known that instability of the system—causing a step change in the nature of the steady state, rather than a smooth change predictable by sensitivity analysis—could be an underlying reason.</p>
<p>The success of the method with these systems presented here shows that it deserves consideration as a design tool in the invention of new pathways. The method has proven versatile enough to successfully predict features in three different pathways investigated in different laboratories and powerful enough to do so without <italic>a priori</italic> knowledge of specific enzyme parameter values. EMRA simulation of a longer and not-yet characterized pathway demonstrates the range of possibilities for potential applications of this technique. While the characterized pathways were optimized based on intuition, it’s possible that a longer pathway with more enzymes, such as the glucose-to-isoprene pathway, would be much more difficult to optimize without rational balancing methods like those presented here. The reduction of search space from 22 to 3 variables represents an exponentially more approachable experimental path towards productivity, resulting in 27 (3<sup>3</sup>) experiments rather than about 10 million (3<sup>21</sup>) if three different enzyme amounts are tested.</p>
<p>Another insight provided by EMRA and follow-up analysis is the determination of failure modes for the pathways investigated. Using parameter and enzyme amount values in stable and unstable regions of the parameter continuation, time domain integration allows us to determine the failure modes for these pathways upon instability. In the MCC pathway, it is depletion of pathway intermediates—especially X5P, R5P and F6P—which causes productivity decline and eventual stopping. Although time domain simulations weren’t carried out in all systems, the demonstration of failure mechanism in the MCC system may lend credence to the other EMRA examples. In the chimeric glycolysis pathway, depletion of ATP eventually caused that pathway to stop when glucose feed rate was too high. Identifying these failure modes with EMRA is another potentially fruitful area of discovery.</p>
<p>Glycolysis is a fundamental pathway of life and functions successfully in many organisms. However, our simulations and previous experiments (<xref ref-type="fig" rid="pcbi.1004800.g006">Fig 6</xref>, [<xref ref-type="bibr" rid="pcbi.1004800.ref017">17</xref>]) have shown it can be unstable under high glucose feed conditions which apparently deplete ATP and accumulate hexose-monophosphates (<xref ref-type="fig" rid="pcbi.1004800.g006">Fig 6D and 6E</xref>). Some hexokinase enzymes are product-inhibited by G6P, [<xref ref-type="bibr" rid="pcbi.1004800.ref022">22</xref>] however, the particular enzyme used in the experimental investigation (from <italic>Thermus thermophilus</italic>) was investigated and no G6P-inhibition was reported.[<xref ref-type="bibr" rid="pcbi.1004800.ref023">23</xref>] Interestingly, glycolysis has also been shown to be unstable to low levels of inorganic phosphate in yeast, a condition which prevents GAPDH from proceeding [<xref ref-type="bibr" rid="pcbi.1004800.ref024">24</xref>]. Glycolysis is a nearly universal pathway, but this evidence shows it to be unstable in some cases. This helps to explain the presence of elaborate regulations such as insulin and glucagon [<xref ref-type="bibr" rid="pcbi.1004800.ref025">25</xref>,<xref ref-type="bibr" rid="pcbi.1004800.ref026">26</xref>] in animals and the massively sophisticated regulation of phosphofructokinase [<xref ref-type="bibr" rid="pcbi.1004800.ref027">27</xref>,<xref ref-type="bibr" rid="pcbi.1004800.ref028">28</xref>] in many organisms. Rather than stability, alternate explanations such as chemical necessity [<xref ref-type="bibr" rid="pcbi.1004800.ref029">29</xref>] and thermodynamic efficiency [<xref ref-type="bibr" rid="pcbi.1004800.ref030">30</xref>,<xref ref-type="bibr" rid="pcbi.1004800.ref031">31</xref>] are more likely reasons for the universality of glycolysis.</p>
<p>In these analyses, EMRA was used to successfully evaluate the stability of complex <italic>cell-free</italic> pathway assays. <italic>In vitro</italic> biocatalysis systems are a powerful alternative and complement to <italic>in vivo</italic> systems [<xref ref-type="bibr" rid="pcbi.1004800.ref032">32</xref>]. Importantly, however, this does not exclude the possibility of success with simulation of <italic>in vivo</italic> systems. Depending on growth mode (exponential growth, stationary phase, fermentation etc.) <italic>in vivo</italic> systems may have different reference fluxes, so more exploration is required to identify different possibilities.</p>
<p>It is unsurprising that lower amounts of pathway enzymes or feed rate would hinder productivity. The powerful insight provided by these results is that for the pathways identified, increasing levels of certain enzymes or feed rates were shown to cause instability and consequently reduce production. A typical metabolic engineering approach may be to simply maximize the reaction rate of all pathway enzymes. However, we show here that for many enzymes, this will not always result in an optimal outcome.</p>
<p>Additionally, we have shown that the intrinsic stability of pathways varies significantly depending on structure and kinetic forms. This highlights the importance of stability analysis in understanding metabolic systems. Additionally, it shows that many metabolic systems may be very difficult to balance without sufficient rational methods for analyzing which enzymes are most likely to contribute to pathway instability, and in which amounts. This shows the importance of EMRA and stability analysis in general in understanding pathways theoretically and exploiting them practically.</p>
<p>The lack of requirement for <italic>a priori</italic> knowledge of specific enzyme parameter values could make EMRA particularly approachable for experimental researchers working with new pathways or unknown enzymes. This may be hampered somewhat by the need for sophisticated mathematical operations, though this obstacle could be overcome if an appropriate software suite is made available. We believe EMRA can significantly contribute to pathway development efforts and is an important contribution to the toolbox of metabolic engineering.</p>
</sec>
<sec id="sec014" sec-type="materials|methods">
<title>Methods</title>
<p>Production systems were described in Systems Description. Stoichiometric matrices for the pathways were constructed based on catalogued and reported reactions. Reversibilities of each enzyme were assigned based on if an enzyme i) is an ATP-dependent kinase ii) catalyzes a reaction with a highly negative ΔG<sup>o</sup> (less than -20kJ), [<xref ref-type="bibr" rid="pcbi.1004800.ref033">33</xref>] or iii) catalyzes a decarboxylation. The functional form used for each reaction used canonical Michaelis-Menten saturation kinetics. Affinity parameters (K<sub>m</sub>) are normalized to substrate concentration to reduce the number of parameters sampled for, and metabolite concentrations are normalized to unity. The normalized forms of the equations are as previously shown [<xref ref-type="bibr" rid="pcbi.1004800.ref007">7</xref>].</p>
<p>For the pathways chosen, exchange reactions were defined for inputs and outputs. Stoichiometric matrices, enzyme reversibilities and reference steady states for all simulations can be found in SI (<xref ref-type="supplementary-material" rid="pcbi.1004800.s002">S1</xref>–<xref ref-type="supplementary-material" rid="pcbi.1004800.s008">S7</xref> Tables).</p>
<p>Ensemble modeling robustness analysis (EMRA) was performed on several enzymatic pathways that have been performed experimentally in the literature. EMRA is a technique which uses knowledge of an enzymatic pathway’s network structure to determine if its steady state is stable to changes in enzyme level. Michaelis-Menten style saturation rate equations are determined for each reaction based on stoichiometry and reversibility. Enzyme parameters are picked randomly to satisfy the reference steady state which is provided. For each enzyme, random values in a 100-fold range with a uniform distribution (from 0.1 to 10 fold of the normalized metabolite concentration) were selected for the scaled affinity parameters (K<sub>m</sub>/[X]<sub>ss,r</sub>) [<xref ref-type="bibr" rid="pcbi.1004800.ref007">7</xref>]. V<sub>max</sub> is solved for using the reference steady state flux value. To confirm the presence of a stable steady state, the system’s Jacobian is confirmed to have eigenvalues with only negative real parts [<xref ref-type="bibr" rid="pcbi.1004800.ref034">34</xref>]. Otherwise, the model is discarded. 1,000 parameter sets were generated this way for each system. For the completely random parameter values, a log-uniform 100-fold range of V<sub>max</sub> parameter was used. For the MCC (Fpk/Xpk 1:3) system, the Fpk and Xpk Vmax were assigned ¼ and ¾, respectively, of the value of a random number generated, to ensure that the overall phosphoketolase amount was controlled. Steady state determination was validated by decreasing integration time by 10-fold, and ensuring that the fraction of 1000 parameter sets which reach steady state was within the SD of the original condition (n = 1000 x 3). V<sub>max</sub> values were generated on a log-uniform scale, while K<sub>m</sub> was generated on a uniform scale. To test if method of generating random values was a significant factor, different methods were tested (all values from a uniform distribution or log-uniform distribution) but no major differences were seen (<xref ref-type="supplementary-material" rid="pcbi.1004800.s009">S8 Table</xref>).</p>
<p>To simulate batch systems from an analogous continuous system (as in the simulation of the MCC system shown in <xref ref-type="fig" rid="pcbi.1004800.g004">Fig 4</xref>), a minimum of changes were made. Functional forms for reaction flux equations were maintained. For the simulations in <xref ref-type="fig" rid="pcbi.1004800.g004">Fig 4</xref>, an arbitrary parameter set was selected from those generated by ensemble modeling. For all rate law reactions used, reaction rate (V<sub>i</sub>) was directly proportional to V<sub>max</sub>. V<sub>max</sub> is multiplied by a function of other parameters, (<inline-formula id="pcbi.1004800.e006"><alternatives><graphic id="pcbi.1004800.e006g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1004800.e006" xlink:type="simple"/><mml:math display="inline" id="M6"><mml:mover accent="true"><mml:mi mathvariant="normal">λ</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math></alternatives></inline-formula> representing K<sub>m,</sub> K<sub>eq</sub>, etc.) and normalized metabolite concentrations (<inline-formula id="pcbi.1004800.e007"><alternatives><graphic id="pcbi.1004800.e007g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1004800.e007" xlink:type="simple"/><mml:math display="inline" id="M7"><mml:mover accent="true"><mml:mtext>x</mml:mtext><mml:mo>¯</mml:mo></mml:mover></mml:math></alternatives></inline-formula>).</p>
<disp-formula id="pcbi.1004800.e008">
<alternatives>
<graphic id="pcbi.1004800.e008g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1004800.e008" xlink:type="simple"/>
<mml:math display="block" id="M8">
<mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>*</mml:mo><mml:mi>f</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mover accent="true"><mml:mi>λ</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo>,</mml:mo><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow>
</mml:math>
</alternatives>
</disp-formula>
<p>To simulate a batch system, exchange reactions are removed by setting their V<sub>max</sub> to 0.</p>
<p>Normalized metabolite concentration values were used for both simulation conditions. To provide a supply of starting substrate, the initial amount of formaldehyde was multiplied by 200. Normalized steady state (continuous) or initial (batch) metabolite concentration (<inline-formula id="pcbi.1004800.e009"><alternatives><graphic id="pcbi.1004800.e009g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1004800.e009" xlink:type="simple"/><mml:math display="inline" id="M9"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mtext>X</mml:mtext><mml:mo>¯</mml:mo></mml:mover><mml:mtext>i</mml:mtext></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>) is shown in this table for continuous and batch simulations. Normalized metabolite amount, <inline-formula id="pcbi.1004800.e010"><alternatives><graphic id="pcbi.1004800.e010g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1004800.e010" xlink:type="simple"/><mml:math display="inline" id="M10"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mtext>X</mml:mtext><mml:mo>¯</mml:mo></mml:mover><mml:mtext>i</mml:mtext></mml:msub></mml:mrow></mml:math></alternatives></inline-formula>, is equal to the actual metabolite concentration, X<sub>i</sub>, divided by the reference steady state concentration, X<sub>i,SS</sub>.</p>
<disp-formula id="pcbi.1004800.e011">
<alternatives>
<graphic id="pcbi.1004800.e011g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1004800.e011" xlink:type="simple"/>
<mml:math display="block" id="M11">
<mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>X</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>S</mml:mi><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow>
</mml:math>
</alternatives>
</disp-formula>
<p>In combination, setting input and output V<sub>max</sub> to 0 and providing starting substrate formaldehyde allows the simulation to run as a batch system accumulating acetate while keeping the other rate equations and parameter values unchanged.</p>
<p>For each parameter set in an ensemble, the steady state is perturbed using parameter-domain integration. This consists of numerically integrating using the continuation method. The mathematical justification for this method has been presented previously [<xref ref-type="bibr" rid="pcbi.1004800.ref007">7</xref>]. At each step in this integration, as an enzyme level is perturbed, the normalized metabolite concentration at the new steady state may be different, so it is necessary to re-compute the numerical values of the Jacobian matrix. If the new Jacobian has an eigenvalue with a positive real part, this indicates system instability [<xref ref-type="bibr" rid="pcbi.1004800.ref034">34</xref>] (<xref ref-type="fig" rid="pcbi.1004800.g001">Fig 1</xref>) and the integration is halted. These computations allow for analysis at every level of enzyme perturbation. For each parameter set in an ensemble, the fraction which were stable (i.e. all Jacobian matrix eigenvalues remain negative) can be plotted versus the level of perturbation for each enzyme.</p>
<p>Simulations were performed in MATLAB, and the code required to reproduce all figures is available at: <ext-link ext-link-type="uri" xlink:href="https://github.com/theis188/theisen-plos-comp-bio" xlink:type="simple">https://github.com/theis188/theisen-plos-comp-bio</ext-link>.</p>
</sec>
<sec id="sec015">
<title>Supporting Information</title>
<supplementary-material id="pcbi.1004800.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1004800.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>EMRA stability profiles for canonical EMP glycolysis converting glucose to lactate with an ATP drain (ATPD).</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1004800.s002" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1004800.s002" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>S, Vref and reversibilities of enzymes for Fpk version of MCC.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1004800.s003" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1004800.s003" xlink:type="simple">
<label>S2 Table</label>
<caption>
<title>S, Vref and reversibilities of enzymes for Xpk version of MCC.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1004800.s004" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1004800.s004" xlink:type="simple">
<label>S3 Table</label>
<caption>
<title>S, Vref and reversibilities of enzymes for X/Fpk version of MCC.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1004800.s005" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1004800.s005" xlink:type="simple">
<label>S4 Table</label>
<caption>
<title>S, Vref and reversibilities of enzymes for chimeric glycolysis pathway.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1004800.s006" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1004800.s006" xlink:type="simple">
<label>S5 Table</label>
<caption>
<title>S, Vref and reversibilities of enzymes for EMP glycolysis pathway with ATP drain.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1004800.s007" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1004800.s007" xlink:type="simple">
<label>S6 Table</label>
<caption>
<title>S, Vref and reversibilities of enzymes for molecular purge pathway.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1004800.s008" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1004800.s008" xlink:type="simple">
<label>S7 Table</label>
<caption>
<title>S, Vref and reversibilities of enzymes for glucose-to-isoprene pathway.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1004800.s009" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1004800.s009" xlink:type="simple">
<label>S8 Table</label>
<caption>
<title>Comparison of different methods for determining random values from <xref ref-type="fig" rid="pcbi.1004800.g003">Fig 3A</xref>.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pcbi.1004800.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rapp</surname> <given-names>P</given-names></name>. <article-title>Oscillations and chaos in cellular metabolism and physiological systems</article-title>. <source>Chaos</source>. <year>1986</year>. pp. <fpage>179</fpage>–<lpage>203</lpage>.</mixed-citation></ref>
<ref id="pcbi.1004800.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hess</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Boiteux</surname> <given-names>a</given-names></name>, <name name-style="western"><surname>Krüger</surname> <given-names>J</given-names></name>. <article-title>Cooperation of glycolytic enzymes</article-title>. <source>Adv Enzyme Regul</source>. <year>1969</year>;<volume>7</volume>: <fpage>149</fpage>–<lpage>167</lpage>. <object-id pub-id-type="pmid">4244004</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mees a</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Rapp</surname> <given-names>PE</given-names></name>. <article-title>Periodic metabolic systems: oscillations in multiple-loop negative feedback biochemical control networks</article-title>. <source>J Math Biol</source>. <year>1978</year>;<volume>5</volume>: <fpage>99</fpage>–<lpage>114</lpage>. <object-id pub-id-type="pmid">731136</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fung</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Wong</surname> <given-names>WW</given-names></name>, <name name-style="western"><surname>Suen</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Bulter</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>S-G</given-names></name>, <name name-style="western"><surname>Liao</surname> <given-names>JC</given-names></name>. <article-title>A synthetic gene–metabolic oscillator</article-title>. <source>Nature</source>. <year>2005</year>;<volume>435</volume>: <fpage>118</fpage>–<lpage>122</lpage>. <object-id pub-id-type="pmid">15875027</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Steuer</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Steuer</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Gross</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Gross</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Selbig</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Selbig</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Structural kinetic modeling of metabolic networks</article-title>. <source>Proc Natl Acad Sci</source>. <year>2006</year>;<volume>103</volume>: <fpage>11868</fpage>–<lpage>11873</lpage>. <object-id pub-id-type="pmid">16880395</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bass</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>JS</given-names></name>. <article-title>Circadian integration of metabolism and energetics</article-title>. <source>Science</source>. <year>2010</year>;<volume>330</volume>: <fpage>1349</fpage>–<lpage>1354</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1195027" xlink:type="simple">10.1126/science.1195027</ext-link></comment> <object-id pub-id-type="pmid">21127246</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Lafontaine</surname> <given-names>Rivera JG</given-names></name>, <name name-style="western"><surname>Liao</surname> <given-names>JC</given-names></name>. <article-title>Ensemble Modeling for Robustness Analysis in engineering non-native metabolic pathways</article-title>. <source>Metab Eng</source>. Elsevier; <year>2014</year>; <fpage>1</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
<ref id="pcbi.1004800.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lafontaine</surname> <given-names>Rivera JG</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Liao</surname> <given-names>JC</given-names></name>. <article-title>An entropy-like index of bifurcational robustness for metabolic systems</article-title>. <source>Integr Biol</source>. <year>2015</year>.</mixed-citation></ref>
<ref id="pcbi.1004800.ref009"><label>9</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Voit</surname> <given-names>E</given-names></name>. <chapter-title>Computational Analysis of Biochemical Systems: A Practical Guide for Biochemists and Molecular Biologists</chapter-title>. <source>First Edit</source>. <publisher-name>Cambridge University Press</publisher-name>; <year>2000</year>.</mixed-citation></ref>
<ref id="pcbi.1004800.ref010"><label>10</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Voit</surname> <given-names>E</given-names></name>. <chapter-title>Canonical Nonlinear Modeling</chapter-title>. <source>First Edit</source>. <publisher-name>Chapman and Hall</publisher-name>; <year>1991</year>.</mixed-citation></ref>
<ref id="pcbi.1004800.ref011"><label>11</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Savageau</surname> <given-names>M</given-names></name>. <chapter-title>Biochemical systems analysis. I. Some mathematical properties of the rate law for the component enzymatic reactions</chapter-title>. <source>J Theor Biol</source>. <year>1969</year>;<volume>25</volume>: <fpage>365</fpage>–<lpage>369</lpage>. <object-id pub-id-type="pmid">5387046</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref012"><label>12</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Savageau</surname> <given-names>MA</given-names></name>. <chapter-title>Development of fractal kinetic theory for enzyme-catalysed reactions and implications for the design of biochemical pathways</chapter-title>. <source>BioSystems</source>. <year>1998</year>;<volume>47</volume>: <fpage>9</fpage>–<lpage>36</lpage>. <object-id pub-id-type="pmid">9715749</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref013"><label>13</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Savageau</surname> <given-names>M</given-names></name>. <source>Biochemical Systems Analysis</source>. <publisher-name>Addison-Wesley</publisher-name>; <year>1976</year>. p. <fpage>379</fpage>.</mixed-citation></ref>
<ref id="pcbi.1004800.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple">Fell D a. Metabolic Control Analysis : experimental development of its theoretical and. <source>Biochem J</source>. <year>1992</year>;<volume>330</volume>: <fpage>313</fpage>–<lpage>330</lpage>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1132899/" xlink:type="simple">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1132899/</ext-link></mixed-citation></ref>
<ref id="pcbi.1004800.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bogorad</surname> <given-names>IW</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>C-T</given-names></name>, <name name-style="western"><surname>Theisen</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>T-Y</given-names></name>, <name name-style="western"><surname>Schlenz</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Lam</surname> <given-names>AT</given-names></name>, <etal>et al</etal>. <article-title>Building carbon-carbon bonds using a biocatalytic methanol condensation cycle</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2014</year>;</mixed-citation></ref>
<ref id="pcbi.1004800.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Opgenorth</surname> <given-names>PH</given-names></name>, <name name-style="western"><surname>Korman</surname> <given-names>TP</given-names></name>, <name name-style="western"><surname>Bowie</surname> <given-names>JU</given-names></name>. <article-title>A synthetic biochemistry molecular purge valve module that maintains redox balance</article-title>. <source>Nat Commun</source>. Nature Publishing Group; <year>2014</year>;<volume>5</volume>: <fpage>4113</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncomms5113" xlink:type="simple">10.1038/ncomms5113</ext-link></comment> <object-id pub-id-type="pmid">24936528</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ye</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Honda</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sakai</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Okano</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Omasa</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Hirota</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Synthetic metabolic engineering-a novel, simple technology for designing a chimeric metabolic pathway</article-title>. <source>Microb Cell Fact</source>. Microbial Cell Factories; <year>2012</year>;<volume>11</volume>: <fpage>120</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1475-2859-11-120" xlink:type="simple">10.1186/1475-2859-11-120</ext-link></comment> <object-id pub-id-type="pmid">22950411</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liebermeister</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Uhlendorf</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Klipp</surname> <given-names>E</given-names></name>. <article-title>Modular rate laws for enzymatic reactions: Thermodynamics, elasticities and implementation</article-title>. <source>Bioinformatics</source>. <year>2010</year>;<volume>26</volume>: <fpage>1528</fpage>–<lpage>1534</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/bioinformatics/btq141" xlink:type="simple">10.1093/bioinformatics/btq141</ext-link></comment> <object-id pub-id-type="pmid">20385728</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Kurbanov</surname> <given-names>FT</given-names></name>, <name name-style="western"><surname>Honzatko</surname> <given-names>RB</given-names></name>, <name name-style="western"><surname>Fromm</surname> <given-names>HJ</given-names></name>. <article-title>Dual mechanisms for glucose 6-phosphate inhibition of human brain hexokinase</article-title>. <source>J Biol Chem</source>. <year>1999</year>;<volume>274</volume>: <fpage>31155</fpage>–<lpage>31159</lpage>. <object-id pub-id-type="pmid">10531306</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bogorad</surname> <given-names>IW</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Theisen</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Schlenz</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Lam</surname> <given-names>AT</given-names></name>. <article-title>Building carbon-carbon bonds using a biocatalytic methanol condensation cycle</article-title>. <source>Proc Natl Acad Sci</source>. <year>2014</year>;<volume>111</volume>: <fpage>15928</fpage>–<lpage>15933</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1413470111" xlink:type="simple">10.1073/pnas.1413470111</ext-link></comment> <object-id pub-id-type="pmid">25355907</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ettema</surname> <given-names>TJG</given-names></name>, <name name-style="western"><surname>Ahmed</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Geerling</surname> <given-names>ACM</given-names></name>, <name name-style="western"><surname>van der Oost</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Siebers</surname> <given-names>B</given-names></name>. <article-title>The non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase (GAPN) of Sulfolobus solfataricus: a key-enzyme of the semi-phosphorylative branch of the Entner-Doudoroff pathway</article-title>. <source>Extremophiles</source>. <year>2008</year>;<volume>12</volume>: <fpage>75</fpage>–<lpage>88</lpage>. <object-id pub-id-type="pmid">17549431</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Renz</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Stitt</surname> <given-names>M</given-names></name>. <article-title>Substrate specificity and product inhibition of different forms of fructokinases and hexokinases in developing potato tubers</article-title>. <source>Planta</source>. <year>1993</year>;<volume>190</volume>: <fpage>166</fpage>–<lpage>175</lpage>.</mixed-citation></ref>
<ref id="pcbi.1004800.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nakamura</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kashima</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Mine</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Oku</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Uegaki</surname> <given-names>K</given-names></name>. <article-title>Characterization and crystal structure of the thermophilic ROK hexokinase from Thermus thermophilus</article-title>. <source>J Biosci Bioeng</source>. <year>2012</year>;<volume>114</volume>: <fpage>150</fpage>–<lpage>154</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jbiosc.2012.03.018" xlink:type="simple">10.1016/j.jbiosc.2012.03.018</ext-link></comment> <object-id pub-id-type="pmid">22591843</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van Heerden</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Wortel</surname> <given-names>MT</given-names></name>, <name name-style="western"><surname>Bruggeman</surname> <given-names>FJ</given-names></name>, <name name-style="western"><surname>Heijnen</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Bollen</surname> <given-names>YJM</given-names></name>, <name name-style="western"><surname>Planque</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Lost in Transition: Start-Up of Glycolysis Yields Subpopulations of Nongrowing Cells</article-title>. <source>Science</source> (80-). <year>2014</year>;<volume>343</volume>: <fpage>1245114</fpage>–<lpage>1245114</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1245114" xlink:type="simple">10.1126/science.1245114</ext-link></comment> <object-id pub-id-type="pmid">24436182</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref025"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Sugano M, Ishiwaki N. soya-bean protein on serum lipids, apolipoproteins, insulin. 1982;</mixed-citation></ref>
<ref id="pcbi.1004800.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Paolisso</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Scheen</surname> <given-names>a J</given-names></name>, <name name-style="western"><surname>Albert</surname> <given-names>a</given-names></name>, <name name-style="western"><surname>Lefebvre</surname> <given-names>PJ</given-names></name>. <article-title>Effects of pulsatile delivery of insulin and glucagon in humans</article-title>. <source>Am J Physiol</source>. <year>1989</year>;<volume>257</volume>: <fpage>E686</fpage>–<lpage>E696</lpage>. <object-id pub-id-type="pmid">2688437</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hofmann</surname> <given-names>E</given-names></name>. <article-title>The significance of phosphofructokinase to the regulation of carbohydrate metabolism</article-title>. <source>Rev Physiol Biochem Pharmacol</source>. <year>1976</year>;<volume>75</volume>: <fpage>1</fpage>–<lpage>68</lpage>. <object-id pub-id-type="pmid">181810</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reeves</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Sols</surname> <given-names>A</given-names></name>. <article-title>Regulation of Escherichia coli Phoshpfructokinase in situ</article-title>. <source>Biochem Biophys Res Commun</source>. <year>1973</year>;<volume>50</volume>: <fpage>459</fpage>–<lpage>466</lpage>. <object-id pub-id-type="pmid">4265975</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bar-Even</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Flamholz</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Noor</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Milo</surname> <given-names>R</given-names></name>. <article-title>Rethinking glycolysis: on the biochemical logic of metabolic pathways</article-title>. <source>Nat Chem Biol</source>. Nature Publishing Group; <year>2012</year>;<volume>8</volume>: <fpage>509</fpage>–<lpage>517</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nchembio.971" xlink:type="simple">10.1038/nchembio.971</ext-link></comment> <object-id pub-id-type="pmid">22596202</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meléndez-Hevia</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Waddell</surname> <given-names>TG</given-names></name>, <name name-style="western"><surname>Heinrich</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Montero</surname> <given-names>F</given-names></name>. <article-title>Theoretical approaches to the evolutionary optimization of glycolysis—chemical analysis</article-title>. <source>Eur J Biochem</source>. <year>1997</year>;<volume>244</volume>: <fpage>527</fpage>–<lpage>543</lpage>. <object-id pub-id-type="pmid">9119021</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Flamholz</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Noor</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Bar-Even</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Liebermeister</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Milo</surname> <given-names>R</given-names></name>. <article-title>Glycolytic strategy as a tradeoff between energy yield and protein cost</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2013</year>;<volume>110</volume>: <fpage>10039</fpage>–<lpage>44</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1215283110" xlink:type="simple">10.1073/pnas.1215283110</ext-link></comment> <object-id pub-id-type="pmid">23630264</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Krutsakorn</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Honda</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Ye</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Imagawa</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Bei</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Okano</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>In vitro production of n-butanol from glucose</article-title>. <source>Metab Eng</source>. Elsevier; <year>2013</year>;<volume>20</volume>: <fpage>84</fpage>–<lpage>91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ymben.2013.09.006" xlink:type="simple">10.1016/j.ymben.2013.09.006</ext-link></comment> <object-id pub-id-type="pmid">24055789</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Flamholz</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Noor</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Bar-Even</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Milo</surname> <given-names>R</given-names></name>. <article-title>eQuilibrator—the biochemical thermodynamics calculator</article-title>. <source>Nucleic Acids Res</source>. <year>2012</year>;<volume>40</volume>: <fpage>D770</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/nar/gkr874" xlink:type="simple">10.1093/nar/gkr874</ext-link></comment> <object-id pub-id-type="pmid">22064852</object-id></mixed-citation></ref>
<ref id="pcbi.1004800.ref034"><label>34</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Arrowsmith</surname> <given-names>D</given-names></name>. <source>Section 3.3. Dynamical Systems</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Chapman &amp; Hall</publisher-name>; <year>1992</year>.</mixed-citation></ref>
</ref-list>
</back>
</article>